Verisk Analytics (VRSK): Is a Move Toward $250 in the Cards?

Key Takeaways

• Selected price target: $250 per share, roughly 34% above Verisk's latest close near $185.79 and above the consensus analyst price target of about $237.71.
• Strongest bullish factors: A mission-critical data franchise serving the property-and-casualty insurance industry, highly recurring subscription revenue, and solid free cash flow generation.
• Biggest risks: Concerns that generative artificial intelligence could disrupt its pricing-data moat, slower organic growth, and elevated valuation relative to peers.
• Key levels: Support sits near the $155.94 52-week low and the $180 area, while resistance builds around $195–$200, the $237 consensus target, and the $250 milestone itself.
• Takeaway: A move to $250 is plausible over a longer horizon but would require reaccelerating growth and investor confidence that Verisk's data advantage withstands AI disruption.

Why the $250 Level Matters

Verisk Analytics, Inc. (VRSK) stands out as one of the more resilient data-analytics businesses, yet its shares have pulled back noticeably over the past year. After peaking near $273.83 in late 2025, the stock has eased to around $185.79, a drop exceeding 30%. This retreat naturally raises the question of whether VRSK can work its way back toward the $250 mark.

That round-number level carries weight. It sits modestly above the average 12-month analyst price target of roughly $237.71, so it represents an ambitious but plausible stretch goal. It also lines up with the upper end of many fair-value estimates in the mid-to-high $200s.

Business Snapshot

Verisk supplies data analytics and technology primarily to property-and-casualty insurers. Its underwriting tools assist with rating, pricing, and risk selection, while claims solutions cover repair cost estimates and antifraud capabilities. After streamlining its portfolio through divestitures, the company now concentrates on this core insurance franchise, where the bulk of revenue arrives through recurring subscription contracts.

That model underpins much of the positive case. Over the trailing twelve months, Verisk reported approximately $3.14 billion in revenue and $885.5 million in net income, with gross margins close to 70%. It also distributes a $2.00 per share dividend, equating to a yield of about 1.08% at current prices. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where the Stock Stands Today

At roughly $185.79, VRSK sits in the middle-to-lower portion of its 52-week range between $155.94 and $273.83. The trailing P/E ratio hovers near 28.6 and the forward P/E near 22.7, consistent with expectations for ongoing earnings growth. With a beta around 0.66, the shares have shown lower volatility than the broader market, reinforcing their reputation as a defensive, cash-generative holding.

Factors That Could Support a Recovery

Several elements could help propel the stock higher. Verisk’s proprietary datasets are deeply integrated into insurer operations, creating switching costs and pricing power. Its subscription revenue base delivers predictable cash flows that support dividends and buybacks. The company is also investing in advanced analytics and AI partnerships that may strengthen rather than erode its position.

If Verisk can maintain mid-single-digit revenue growth, expand margins, and show that AI tools complement its offerings, investors could reward the stock with a higher valuation multiple.

Obstacles to Consider

The main headwind remains uncertainty around AI disruption. Some observers worry that generative AI could allow insurers to develop in-house solutions or enable new entrants to challenge Verisk’s data advantage. Slower organic growth and acquisition-related debt have also tempered sentiment. A recent Delaware court ruling requiring the company to move forward with its planned $2.35 billion purchase of AccuLynx added to the pressure, though Verisk has indicated it may appeal.

Wall Street Views and Targets

Analyst sentiment stays largely positive, though expectations have moderated. Aggregated data point to a consensus 12-month price target near $237.71, suggesting about 28% upside from recent levels, with individual targets spanning roughly $185 to as high as $275–$320. The overall rating is a “Buy,” yet most forecasts now cluster in the low-to-mid $200s, so reaching $250 would mean surpassing the average estimate.

Important Technical Levels

From a technical standpoint, the $155.94 52-week low marks the primary support zone, with further support near $180. On the upside, resistance appears around $195–$200, roughly aligning with the 200-day moving average. Beyond that, the $237 consensus target and the $250 level stand out as the next hurdles that would need to be cleared with conviction and volume.

Valuation Context

Trading at a trailing P/E near 28.6 and forward P/E near 22.7, Verisk commands a premium to certain peers such as Equifax Inc. (EFX). This premium reflects the quality and recurring nature of its revenue, but it also leaves the stock vulnerable to multiple compression if growth or margins disappoint. Achieving $250 would likely require both earnings expansion and a steady or expanding multiple.

Monitoring Momentum with AI Tools

From what I see, staying on top of shifting trends in names like VRSK benefits from systematic signals. In my own process, I’ve found Tickeron’s AI Daily Buy/Sell Signals useful for spotting momentum changes across a broad universe of stocks and ETFs. The tool applies artificial intelligence to generate Buy, Sell, or Hold indications based on technical and market factors, which can help flag potential setups or confirm existing views without replacing broader fundamental work.

Putting It All Together

A return to the $250 area looks feasible over time but is unlikely to happen quickly. Verisk’s entrenched role in insurance data, recurring revenue stream, and free cash flow generation remain its core strengths. Offsetting these are questions around AI disruption, subdued organic growth, and the AccuLynx acquisition overhang. For the target to feel more attainable, sustained revenue acceleration, margin stability, and clearer evidence that its data moat is holding would be needed. In the meantime, the $195–$200 zone and the $237 consensus level are the nearer milestones to watch.

Promo Section

I’ve found Tickeron’s AI Daily Buy/Sell Signals helpful when tracking stocks like VRSK for potential turning points. The platform scans thousands of securities with AI-driven analysis to surface Buy, Sell, or Hold signals based on current conditions. It’s become a regular part of how I monitor positions and identify new opportunities without replacing deeper research.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Industry description

Market Cap

High and low price notable news

Volume